{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:58:07Z","timestamp":1772103487199,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council"},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atrial fibrillation (AF) is classically categorised by arrhythmia duration, but these subtypes have limitations in capturing mechanistic and prognostic diversity. A variational autoencoder, trained on &gt;1.1M ECGs, extracted representative features, filtered for an AF cohort of 20,291 unique patients. These features were input into an unsupervised tree-based clustering method to map AF heterogeneity as a tree structure and identify phenogroups. Five phenogroups stratified by future disease risk were identified: (1) higher-risk AF; (2) highest-risk AF with heart failure (HF); (3) average paroxysmal AF; (4) lower-risk paroxysmal AF; and (5) higher-risk paroxysmal AF. The tree trajectory positioned individuals based on shared traits, emphasising explainability. Paroxysmal phenogroups 4 and 5 differed in risk and ventricular structure, with phenogroup 5 exhibiting more adverse features. Mixed AF phenogroup 2 reflected advanced AF with greater HF burden and mortality risk. This AI-ECG framework augments AF subtypes with a risk-based dimension, supporting personalised care.<\/jats:p>","DOI":"10.1038\/s41746-025-02159-z","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T11:18:13Z","timestamp":1764847093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deriving novel atrial fibrillation phenotypes using a tree-based artificial intelligence-enhanced electrocardiography approach"],"prefix":"10.1038","volume":"8","author":[{"given":"Mehak","family":"Gurnani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Patlatzoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libor","family":"Pastika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boroumand","family":"Zeidaabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Antoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riyaz","family":"Somani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Andre Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Curran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Declan","family":"O\u2019Regan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Waks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunashis","family":"Sau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu Siong","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2159_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","volume":"20","author":"AD Elliott","year":"2023","unstructured":"Elliott, A. D., Middeldorp, M. E., Van Gelder, I. C., Albert, C. M. & Sanders, P. Epidemiology and modifiable risk factors for atrial fibrillation. Nat. Rev. Cardiol. 20, 404\u2013417 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"2159_CR2","doi-asserted-by":"publisher","first-page":"i4482","DOI":"10.1136\/bmj.i4482","volume":"354","author":"A Odutayo","year":"2016","unstructured":"Odutayo, A. et al. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 354, i4482 (2016).","journal-title":"BMJ"},{"key":"2159_CR3","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar, J. A. et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 149, e9\u2013e10 (2024).","journal-title":"Circulation"},{"key":"2159_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrcardio.2010.86","volume":"7","author":"SA Lubitz","year":"2010","unstructured":"Lubitz, S. A., Benjamin, E. J., Ruskin, J. N., Fuster, V. & Ellinor, P. T. Challenges in the classification of atrial fibrillation. Nat. Rev. Cardiol. 7, 451\u2013460 (2010).","journal-title":"Nat. Rev. Cardiol."},{"key":"2159_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jjcc.2022.12.010","volume":"81","author":"H Wada","year":"2023","unstructured":"Wada, H. et al. Impact of atrial fibrillation type (paroxysmal vs. non-paroxysmal) on long-term clinical outcomes: the RAFFINE registry subanalysis. J. Cardiol. 81, 450\u2013455 (2023).","journal-title":"J. Cardiol."},{"key":"2159_CR6","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","volume":"37","author":"AN Ganesan","year":"2016","unstructured":"Ganesan, A. N. et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur. Heart J. 37, 1591\u20131602 (2016).","journal-title":"Eur. Heart J."},{"key":"2159_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","volume":"36","author":"BA Steinberg","year":"2015","unstructured":"Steinberg, B. A. et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur. Heart J. 36, 288\u2013296 (2015).","journal-title":"Eur. Heart J."},{"key":"2159_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","volume":"31","author":"L Friberg","year":"2010","unstructured":"Friberg, L., Hammar, N. & Rosenqvist, M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur. Heart J. 31, 967\u2013975 (2010).","journal-title":"Eur. Heart J."},{"key":"2159_CR9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/europace\/euv390","volume":"18","author":"G Boriani","year":"2016","unstructured":"Boriani, G. et al. \u2018Real-world\u2019 management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry. Europace 18, 648\u2013657 (2016).","journal-title":"Europace"},{"key":"2159_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/jamacardio.2017.4665","volume":"3","author":"T Inohara","year":"2018","unstructured":"Inohara, T. et al. Association of atrial fibrillation clinical phenotypes with treatment patterns and outcomes: a Multicenter Registry study. JAMA Cardiol. 3, 54\u201363 (2018).","journal-title":"JAMA Cardiol."},{"key":"2159_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.amjcard.2019.05.071","volume":"124","author":"T Inohara","year":"2019","unstructured":"Inohara, T. et al. A cluster analysis of the Japanese multicenter outpatient Registry of patients with atrial fibrillation. Am. J. Cardiol. 124, 871\u2013878 (2019).","journal-title":"Am. J. Cardiol."},{"key":"2159_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/biomedicines9070843","volume":"9","author":"M Vitolo","year":"2021","unstructured":"Vitolo, M., Proietti, M., Shantsila, A., Boriani, G. & Lip, G. Y. H. Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes. Biomedicines 9, 843 (2021).","journal-title":"Biomedicines"},{"key":"2159_CR13","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/europace\/euab079","volume":"23","author":"H Ogawa","year":"2021","unstructured":"Ogawa, H. et al. Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry. Europace 23, 1369\u20131379 (2021).","journal-title":"Europace"},{"key":"2159_CR14","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1136\/heartjnl-2023-322447","volume":"109","author":"Y Saito","year":"2023","unstructured":"Saito, Y. et al. Phenotyping of atrial fibrillation with cluster analysis and external validation. Heart 109, 1751\u20131758 (2023).","journal-title":"Heart"},{"key":"2159_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/jpm12050785","volume":"12","author":"D Pastori","year":"2022","unstructured":"Pastori, D. et al. Clinical phenotypes of atrial fibrillation and mortality risk\u2014a cluster analysis from the nationwide Italian START registry. J. Pers. Med. 12, 785 (2022).","journal-title":"J. Pers. Med."},{"key":"2159_CR16","first-page":"100885","volume":"37","author":"E Watanabe","year":"2021","unstructured":"Watanabe, E. et al. Clinical phenotypes of patients with non-valvular atrial fibrillation as defined by a cluster analysis: a report from the J-RHYTHM registry. Int. J. Cardiol. Heart Vasc. 37, 100885 (2021).","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"2159_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/qjmed\/hcad219","volume":"117","author":"R Krittayaphong","year":"2024","unstructured":"Krittayaphong, R., Treewaree, S., Wongtheptien, W., Kaewkumdee, P. & Lip, G. Y. H. Clinical phenotype classification to predict risk and optimize the management of patients with atrial fibrillation using the Atrial Fibrillation Better Care (ABC) pathway: a report from the COOL-AF registry. QJM 117, 16\u201323 (2024).","journal-title":"QJM"},{"key":"2159_CR18","doi-asserted-by":"publisher","first-page":"101732","DOI":"10.1016\/j.cpcardiol.2023.101732","volume":"48","author":"A Bisson","year":"2023","unstructured":"Bisson, A. et al. Clinical phenotypes and atrial fibrillation recurrences after catheter ablation: an unsupervised cluster analysis. Curr. Probl. Cardiol. 48, 101732 (2023).","journal-title":"Curr. Probl. Cardiol."},{"key":"2159_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12916-021-02120-3","volume":"19","author":"M Proietti","year":"2021","unstructured":"Proietti, M. et al. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry. BMC Med. 19, 256 (2021).","journal-title":"BMC Med."},{"key":"2159_CR20","doi-asserted-by":"publisher","first-page":"105280","DOI":"10.1016\/j.ebiom.2024.105280","volume":"107","author":"RAA Bellfield","year":"2024","unstructured":"Bellfield, R. A. A. et al. AI-based derivation of atrial fibrillation phenotypes in the general and critical care populations. EBioMedicine 107, 105280 (2024).","journal-title":"EBioMedicine"},{"key":"2159_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1136\/heartjnl-2023-322812","volume":"109","author":"A Sau","year":"2023","unstructured":"Sau, A., Pastika, L. & Ng, F. S. Atrial fibrillation phenotypes: the route to personalised care?. Heart 109, 1727\u20131728 (2023).","journal-title":"Heart"},{"key":"2159_CR22","doi-asserted-by":"crossref","unstructured":"Ng, F. S., Handa B. S., Li, X. & Peters, N. S. Toward mechanism-directed electrophenotype-based treatments for atrial fibrillation. Front. Physiol. 11, 987 (2020).","DOI":"10.3389\/fphys.2020.00987"},{"key":"2159_CR23","doi-asserted-by":"publisher","first-page":"e004200","DOI":"10.1161\/CIRCGEN.123.004200","volume":"16","author":"L Curran","year":"2023","unstructured":"Curran, L. et al. Genotype\u2013phenotype taxonomy of hypertrophic cardiomyopathy. Circ. Genom. Precis. Med. 16, e004200 (2023).","journal-title":"Circ. Genom. Precis. Med."},{"key":"2159_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/110668","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell developmental trajectories. bioRxiv https:\/\/doi.org\/10.1101\/110668 (2017) .","journal-title":"bioRxiv"},{"key":"2159_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/ehjdh\/ztac038","volume":"3","author":"RR Van de Leur","year":"2022","unstructured":"Van de Leur, R. R. et al. Improving explainability of deep neural network-based electrocardiogram interpretation using variational auto-encoders. Eur. Heart J. Digit. Health 3, 390\u2013404 (2022).","journal-title":"Eur. Heart J. Digit. Health"},{"key":"2159_CR26","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","volume":"28","author":"ATN Nair","year":"2022","unstructured":"Nair, A. T. N. et al. Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes. Nat. Med. 28, 982\u2013988 (2022).","journal-title":"Nat. Med."},{"key":"2159_CR27","doi-asserted-by":"publisher","first-page":"e040814","DOI":"10.1161\/JAHA.124.040814","volume":"14","author":"M Gurnani","year":"2025","unstructured":"Gurnani, M. et al. Revisiting abnormalities of ventricular depolarization: redefining phenotypes and associated outcomes using tree-based dimensionality reduction. J. Am. Heart Assoc. 14, e040814 (2025).","journal-title":"J. Am. Heart Assoc."},{"key":"2159_CR28","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).","journal-title":"PLoS Med."},{"key":"2159_CR29","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry, A. et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am. J. Epidemiol. 186, 1026\u20131034 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"2159_CR30","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","volume":"107","author":"TJ Wang","year":"2003","unstructured":"Wang, T. J. et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107, 2920\u20132925 (2003).","journal-title":"Circulation"},{"key":"2159_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","volume":"11","author":"MA Mamas","year":"2009","unstructured":"Mamas, M. A. et al. A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur. J. Heart Fail. 11, 676\u2013683 (2009).","journal-title":"Eur. J. Heart Fail."},{"key":"2159_CR32","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1093\/eurheartj\/ehad592","volume":"44","author":"JA Naser","year":"2023","unstructured":"Naser, J. A. et al. Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications. Eur. Heart J. 44, 5049\u20135060 (2023).","journal-title":"Eur. Heart J."},{"key":"2159_CR33","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1093\/eurheartj\/ehad747","volume":"44","author":"RM Inciardi","year":"2023","unstructured":"Inciardi, R. M. & Solomon, S. D. Beyond the rhythm: atrial fibrillation, diastolic dysfunction, and heart failure. Eur. Heart J. 44, 5061\u20135063 (2023).","journal-title":"Eur. Heart J."},{"key":"2159_CR34","doi-asserted-by":"publisher","first-page":"euae204","DOI":"10.1093\/europace\/euae204","volume":"26","author":"A Goette","year":"2024","unstructured":"Goette, A. et al. Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace 26, euae204 (2024).","journal-title":"Europace"},{"key":"2159_CR35","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","volume":"383","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof, P. et al. Early rhythm-control therapy in patients with atrial fibrillation. N. Engl. J. Med. 383, 1305\u20131316 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2159_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","volume":"144","author":"A Rillig","year":"2021","unstructured":"Rillig, A. et al. Early rhythm control therapy in patients with atrial fibrillation and heart failure. Circulation 144, 845\u2013858 (2021).","journal-title":"Circulation"},{"key":"2159_CR37","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/CIRCULATIONAHA.122.060274","volume":"146","author":"A Rillig","year":"2022","unstructured":"Rillig, A. et al. Early rhythm control in patients with atrial fibrillation and high comorbidity burden. Circulation 146, 836\u2013847 (2022).","journal-title":"Circulation"},{"key":"2159_CR38","doi-asserted-by":"publisher","first-page":"107798","DOI":"10.1016\/j.cmpb.2023.107798","volume":"242","author":"HF Stabenau","year":"2023","unstructured":"Stabenau, H. F. & Waks, J. W. BRAVEHEART: open-source software for automated electrocardiographic and vectorcardiographic analysis. Comput. Methods Prog. Biomed. 242, 107798 (2023).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"2159_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41591-018-0240-2","volume":"25","author":"ZI Attia","year":"2019","unstructured":"Attia, Z. I. et al. Screening for cardiac contractile dysfunction using an artificial intelligence\u2013enabled electrocardiogram. Nat. Med. 25, 70\u201374 (2019).","journal-title":"Nat. Med."},{"key":"2159_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/ehjdh\/ztac042","volume":"3","author":"A Sau","year":"2022","unstructured":"Sau, A. et al. Artificial intelligence-enabled electrocardiogram to distinguish cavotricuspid isthmus dependence from other atrial tachycardia mechanisms. Eur. Heart J.\u2014Digit. Health 3, 405\u2013414 (2022).","journal-title":"Eur. Heart J.\u2014Digit. Health"},{"key":"2159_CR41","unstructured":"Burgess, C. P. et al. Understanding disentangling in \u03b2-VAE. Preprint at https:\/\/arxiv.org\/abs\/1804.03599 (2018)."},{"key":"2159_CR42","unstructured":"Higgins, I. et al. Beta-VAE: learning basic visual concepts with a constrained variational framework. In International Conference on Learning Representations (2017)."},{"key":"2159_CR43","unstructured":"Garrett, H. et al. Representation learning for improved interpretability and classification accuracy of clinical factors from EEG. Preprint at arXiv http:\/\/arxiv.org\/abs\/2010.15274 (2020)."},{"key":"2159_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15432-4","volume":"11","author":"AH Ribeiro","year":"2020","unstructured":"Ribeiro, A. H. et al. Automatic diagnosis of the 12-lead ECG using a deep neural network. Nat. Commun. 11, 1760 (2020).","journal-title":"Nat. Commun."},{"key":"2159_CR45","unstructured":"Trapnell, C. Monocle (Bioconductor, 2017)."},{"issue":"March","key":"2159_CR46","doi-asserted-by":"publisher","first-page":"1139967","DOI":"10.3389\/fcvm.2023.1139967","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Prognostic value of index of cardiac electrophysiological balance among us middle-aged adults. Front. Cardiovasc. Med. 10 (March), 1139967 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"2159_CR47","first-page":"100884","volume":"37","author":"ACA Rao","year":"2021","unstructured":"Rao, A. C. A. et al. Electrocardiographic QRS duration is influenced by body mass index and sex. Int. J. Cardiol. Heart Vasc. 37, 100884 (2021). 100884.","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"2159_CR48","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/jama.2020.1267","volume":"323","author":"MJ Stensrud","year":"2020","unstructured":"Stensrud, M. J. & Hern\u00e1n, M. A. Why test for proportional hazards? JAMA 323, 1401\u20131402 (2020).","journal-title":"JAMA"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02159-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T13:02:28Z","timestamp":1766408548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02159-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2159"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-02159-z","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.W.W. and D.B.K. were previously on the advisory board for Heartcor Solutions LLC, for whom they remain independent consultants. J.W.W. reports research funding from Anumana and is a consultant for HeartBeam Inc. D.B.K. reports consulting for the Peterson Health Technology Institute and Whoop, Inc. F.S.N. reports speaker fees from GE Healthcare and is on the advisory board for AstraZeneca. The remaining authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"779"}}